SCYNEXIS delays initiation of new clinical studies using the IV formulation of SCY-078 at FDA’s request - Yahoo Finance
tornata buona per me visto che a sti livelli e anche piu su gli insider han comprato tempo fa
Angulo Gonzalez David Chief Medical Officer Dec 16 Buy 3.25 4,000 13,000 46,000 Dec 19 06:44 AM
Machado Patrick Director Sep 15 Buy 2.94 40,000 117,600 60,000 Sep 16 08:50 AM
Angulo Gonzalez David Chief Medical Officer Jun 30 Buy 2.23 32,150 71,695 41,000 Jul 01 10:31 AM
Angulo Gonzalez David Chief Medical Officer Jun 29 Buy 2.18 4,800 10,464 8,850 Jul 01 10:31 AM
Francois Eric Chief Financial Officer Jun 24 Buy 2.39 15,000 35,850 15,000 Jun 28 07:53 AM
Machado Clarence Patrick Director Jun 24 Buy 2.39 20,000 47,800 20,000 Jun 28 07:53 AM
Macdonald Guy Director Jun 24 Buy 2.39 40,000 95,600 40,000 Jun 28 07:52 AM
Taglietti Marco Chief Executive Officer Jun 24 Buy 2.39 100,000 239,000 225,000 Jun 28 07:53 AM
Taglietti Marco Chief Executive Officer May 25 Buy 3.20 246 787 125,000 May 27 03:54 PM
HANHAM ANN Director May 25 Buy 3.64 4,225 15,379 4,225 May 27 01:53 PM
Taglietti Marco Chief Executive Officer May 25 Buy 3.26 5,754 18,758 124,754 May 27 09:16 AM
Taglietti Marco Chief Executive Officer May 24 Buy 3.37 5,500 18,535 119,000 May 25 09:00 AM
Taglietti Marco Chief Executive Officer May 23 Buy 3.15 3,000 9,450 113,500 May 24 09:30 AM
Taglietti Marco Chief Executive Officer May 20 Buy 3.14 4,500 14,130 110,500 May 24 09:30 AM
Taglietti Marco Chief Executive Officer May 19 Buy 3.07 6,000 18,420 106,000 May 20 08:06 AM
open in yahoo | open in reuters | open in google
anche se potrebbe scendere a chiudere gap
ieri avrebbe dovuto dare earning ma non vi è traccia per ora